GHK-Cu (Copper Peptide)
AHK-Cu vs GHK-Cu
AHK-Cu is alanyl-histidyl-lysine copper; GHK-Cu is glycyl-histidyl-lysine copper. They differ at the first residue — alanine instead of glycine — which makes AHK-Cu slightly larger and more hydrophobic. GHK-Cu occurs naturally in human plasma; AHK-Cu is a synthetic analogue with a much smaller literature.
Key facts
- GHK-Cu first residue
- Glycine
- AHK-Cu first residue
- Alanine
- Occurs naturally
- GHK-Cu only
- Marketed mainly for
- AHK-Cu: hair
- Size of literature
- GHK-Cu far larger
One residue, and what it changes
Glycine has a hydrogen side chain; alanine has a methyl group. Swapping one for the other adds a small amount of mass and hydrophobicity without altering the histidine and lysine residues that do most of the copper coordination. The copper binding site is therefore broadly preserved, which is why AHK-Cu behaves as a copper carrier at all.
Only one of them is a human peptide
GHK was isolated from human plasma in 1973 and is a naturally occurring fragment with a documented age-related decline. AHK-Cu is a designed analogue. That distinction matters for any argument that rests on the peptide being something the body already makes — an argument that applies to GHK-Cu and not to AHK-Cu.
Research material referenced
GHK-Cu 100mg — third-party HPLC tested
Why AHK-Cu appears in hair products
AHK-Cu is more often formulated into hair products, on the basis of early work suggesting effects on follicles. The evidence base is considerably smaller than GHK-Cu's, which is itself limited. The marketing separation between the two is sharper than the evidence separating them.
They are not interchangeable
Findings for one do not transfer to the other. Because most published copper peptide work concerns GHK-Cu, claims made for AHK-Cu products frequently rest on GHK-Cu studies. That substitution is not valid, and it is worth checking which peptide a cited study actually used.
Quick reference
| GHK-Cu | AHK-Cu | |
|---|---|---|
| Sequence | Gly-His-Lys | Ala-His-Lys |
| Occurs in humans | Yes | No |
| Discovered / designed | Isolated 1973 | Synthetic analogue |
| Marketed mainly for | Skin | Hair |
| Published literature | Substantial | Sparse |
Extended research context
The GHK-Cu (Copper Peptide) deep dive
Deep dive: why the copper ion matters
The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically — nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.
GHK-Cu in the transcriptomic literature
The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses — including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.
Analytical fingerprinting of GHK-Cu
On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.
Research applications
- ▸In vitro fibroblast and keratinocyte gene-expression studies
- ▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
- ▸Wound-healing scratch assays in cell culture models
- ▸Antioxidant-mechanism studies (copper redox modulation)
- ▸Formulation R&D: cosmetic and topical carrier compatibility research
Handling checklist
- ✓Store lyophilised vial at 2–8 °C, protected from light
- ✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
- ✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
- ✓Aliquot reconstituted solution for freeze/thaw minimisation
- ✓Verify blue colour and CoA HPLC ≥98% before use
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Buying GHK without copper
Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.
✗ Mixing with vitamin C in solution
Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex — keep them separate.
✗ Exposing to sunlight
Fix: Store in amber vial or foil-wrapped container at 2–8 °C.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- Is GHK-Cu the same as copper peptide?
- What does GHK-Cu do in research studies?
- Is GHK-Cu safe for topical formulation research?
- What concentration of GHK-Cu is used in cell culture?
- How is GHK-Cu different from GHK alone?
Frequently asked questions
- What is the difference between AHK-Cu and GHK-Cu?
- The first amino acid. GHK-Cu begins with glycine, AHK-Cu with alanine. GHK-Cu occurs naturally in human plasma; AHK-Cu is a synthetic analogue with a much smaller evidence base.
- Is AHK-Cu better than GHK-Cu?
- No comparison supports that. AHK-Cu is more often marketed for hair, but its published literature is considerably thinner and no head-to-head study exists.
- Can AHK-Cu studies be applied to GHK-Cu?
- No, and the reverse substitution is more common — AHK-Cu products citing GHK-Cu research. Check which peptide a cited study actually used.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedPickart L, The human tri-peptide GHK and tissue remodeling — J Biomater Sci Polym Ed 2008 (PMID 18644225)pubmed.ncbi.nlm.nih.gov
- PubMedPubMed — copper peptide literaturepubmed.ncbi.nlm.nih.gov
- PubMedPickart L & Margolina A, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration — Biomed Res Int 2015 (PMID 26236730)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L et al., The Effect of the Human Peptide GHK on Gene Expression — Brain Sci 2017 (PMID 28212278)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Glycyl-L-histidyl-L-lysine (CID 73587)pubchem.ncbi.nlm.nih.gov
- PubChemPubChem · GHK-Cu copper complex (CID 71587328)pubchem.ncbi.nlm.nih.gov
- PubMedNIH PubMed — GHK-Cu wound healing literaturepubmed.ncbi.nlm.nih.gov
- GuidelineGoogle — Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
Jack Muncaster · Founder, UK Peptides
Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.
More GHK-Cu (Copper Peptide) articles
- What Is GHK-Cu? The Copper Complex Isolated in 1973GHK-Cu is the copper(II) complex of the tripeptide glycyl-histidyl-lysine, isolated from human plasma in 1973. Structure, mechanism and the published evidence.
- GHK-Cu Molecular Weight, and Why Published Figures DifferFree GHK is 340.38 Da; the copper complex is 402.92 Da. Multiple PubChem entries exist at different charge states, which is why figures vary between sources.
- GHK vs GHK-Cu: The Free Tripeptide and the Copper ComplexGHK is the free tripeptide at 340.38 Da; GHK-Cu is the copper complex at 402.92 Da. Why the distinction changes what a paper is actually reporting.
- How GHK Binds CopperThe N-terminal amine, backbone nitrogen and histidine imidazole form a copper-binding site. Why this arrangement has high affinity and what it displaces.
- How GHK Was DiscoveredPickart found that plasma from young donors changed protein synthesis in older liver tissue. The active fraction was a tripeptide, isolated from albumin in 1973.
Popular across the research hub
One flagship guide from every other research category — keep exploring.
- Retatrutide ResearchRetatrutide: What the Trials Show For and Against
- TB-500 (Thymosin β4 fragment)How Thymosin Beta-4 Was Discovered
- BPC-157 (Pentadecapeptide)BPC-157 vs TB-500 Compared
- CJC-1295 & IpamorelinGHRH and Ghrelin: Two Separate Pathways
- Peptide ReferenceHow to Read a Certificate of Analysis
- Bacteriostatic WaterWhat Is Bacteriostatic Water? Composition and Specification
- Research & Regulatory NewsThe Correction Nobody Reads
- GLP-1 & Incretin ScienceHow Many People Are Still Taking It a Year Later
- MOTS-c (Mitochondrial Peptide)MOTS-c Structure, Sequence and Physical Properties
- Semax (ACTH Fragment Peptide)Semax Structure, Sequence and Physical Properties
- Selank (Tuftsin Analogue)Selank's Enkephalinase Mechanism
- DSIP (Delta Sleep-Inducing Peptide)An Antibody Reports What It Binds, Not What Is There
- KLOW (Blend)Equal Milligrams Is Not Equal Molecules
- GLOW (Blend)What Is GLOW? GHK-Cu, BPC-157 and TB-500
- MT-2 (Melanotan II)MT-2 Chemical Identity and the Database Trap
- IGF-1 LR3A Natural Experiment in Absent IGF-1
- GlutathioneGlutathione Proposed as a Carrier, Not Just a Buffer
- NAD+Eighty Daltons Apart, and Metabolically Opposed
- KPVThe Transporter That Explains the Tripeptide